Document 6RVvbwq3OOnoQx0zvY2dQRXGo

CHEMICAL MANUFACTURERS ASSOCIATION August 18, 1994 James Swenberg Department of Environmental Sciences and Engineering University of North Carolina Campus Box 7400 Rosenau Hall Chapel Hill, NC 27599-7400 Dear Dr, Swenberg: A copy of my correspondence with EPA on vinyl chloride risk assessment is enclosed. 1 plan to arrange a conference call in mid-September to coordinate the Vinyl Chloride Panel presentation to EPA on Richard Reitz's pharmacokinetic model. The conference call would include Richard Reitz, Jonathan Ramlow (Dow), Jim Knaak (Oxy), you and myself. Meanwhile, please review the enclosed' material in light of your recent research findings to see if the data can further aid vinyl chloride risk assessment. I will contact you shortly to confirm the EPA meeting and explore possible dates for the conference call. ^ If you have any questions, please contact me at (202) 887-1192. Sincerely, Enclosures Hasmukh C. Shah, Ph.D. Manager, Vinyl Chloride Panel 2501 M Street. NW. Washington, DC 20037 Telephone 202-887-1100 Fax 202-887-1237 Responsible Cart * A Public Commitment CMA121015